BioSpace News Archive

FDA

Lecanemab granted Fast Track designation by the FDA

BioArctic AB’s was granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

December 23, 2021
·
6 min read
LumiraDx COVID-19 & Flu A/B Rapid Antigen Test Achieves CE Marking

LumiraDx, a next-generation point of care diagnostics company, announced its SARS-CoV-2 & Flu A/B Antigen Test has achieved CE Marking.

December 23, 2021
·
5 min read
Pharm Country

Henry Schein to Present at the 40th Annual J.P. Morgan Healthcare Investor Conference

Henry Schein to Present at the 40th Annual J.P. Morgan Healthcare Investor Conference.

December 23, 2021
·
2 min read
Business

Aarvik Therapeutics and ArriVent Biopharma Announce Research Collaboration to Advance Novel Oncology Drug Candidate Using Aarvik’s Proprietary Modular Antibody Platform

Aarvik Therapeutics and ArriVent Biopharma Inc. today announced a strategic research collaboration to develop and commercialize an undisclosed oncology-focused drug candidate.

December 23, 2021
·
3 min read
BioCapital

EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities

EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities.

December 23, 2021
·
13 min read
Deals

Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics

Quidel Corporation today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho.

December 23, 2021
·
15 min read
Business

XOMA Declares Quarterly Preferred Stock Dividends - Dec 23, 2021

XOMA Corporation announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferred Stock.

December 23, 2021
·
3 min read
Biotech Beach

Arcutis Biotherapeutics Secures $225 Million in Non-Dilutive Debt Financing from SLR Capital Partners

Arcutis Biotherapeutics, Inc. today announced that it has obtained a $225 million term loan facility from funds managed by SLR Capital Partners (“SLR”).

December 23, 2021
·
5 min read
Biotech Beach

Codex DNA Expands Catalog of COVID-19 Tools with Release of Full-Length Synthetic Genome for SARS-CoV-2 Omicron Variant

Codex DNA, Inc. today announced the release of a new full-length synthetic genome of the SARS-CoV-2 virus for the highly mutated and contagious Omicron variant (B.1.1.529 lineage).

December 23, 2021
·
3 min read
Femasys Inc. to Participate in Upcoming January Investor Conferences

Femasys Inc. today announced that the Company is participating in the LifeSci Partners 11th Annual Corporate Access Event, which will be held virtually from January 5-7, 2022.

December 23, 2021
·
1 min read